Definitive Healthcare Announces Expanded Solutions for Biopharma and Medical Device Companies

Framingham, MA - Definitive Healthcare today announced significant enhancements to its solution suites for biopharma companies and medical device manufacturers. New real-time insights will help clients further leverage the industry’s most comprehensive, accurate solution to accelerate their go-to-market strategy.

The new capabilities include:

• A three-fold increase in the prescription claims coverage available in the company’s Rx Claims Data expansion module;
• Powerful new data and analytics on physician affiliations, including historical affiliations and affiliation strength; and
• New insights on telemedicine adoption and utilization across more than two million healthcare professionals in the United States.

“Today’s increasingly complex healthcare marketplace requires both market context and market contacts,” said Jason Krantz, founder and CEO of Definitive Healthcare. “These new solutions provide life sciences clients with comprehensive market data to help them develop a go-to-market strategy, and then deliver the detailed account-level contact information needed to win deals.”

The expanded solutions will provide biopharma and medical device clients with better insight to target healthcare professionals and prescribers with profiles that are most aligned with a drug, therapy, or device.

“As avid users of Definitive Healthcare, we are excited about the additional insight that will come from the expanded pharmacy claim data,” said Stan Alie, GPO National Account Director at Boehringer-Ingelheim Pharmaceuticals. “This data will help us navigate the ever-changing healthcare landscape and provide us with the information we need to make well-informed decisions for the patients we serve.”

Significantly Enhanced Prescription Claims Coverage

Definitive Healthcare has more than tripled the company’s prescription drug claims database to cover nearly 250 million patient lives. This enhanced coverage will allow clients to evaluate market potential, allocate investment resources and fine-tune go-to-market planning.

“By harmonizing de-identified prescription claims data with provider data like procedure history & referral networks, our life sciences clients can make better and more informed decisions across a range of functions from market intelligence to managed markets to sales operations,” said Kate Shamsuddin Jensen, Chief Product Officer at Definitive Healthcare. “With this expanded dataset, Definitive Healthcare clients can leverage real-time analytics on prescriber volumes and behaviors to identify unique patterns.”

Enhanced Physicians Affiliation Mapping

The enhancements to the Physicians database product announced today give subscribers access to expanded data about physician affiliations with hospitals, integrated delivery networks, long-term care facilities, ambulatory service centers, and imaging centers. This data provides unmatched insights, including visual representation, into how a healthcare professional is connected to the healthcare ecosystem, the strength of those relationships, and how those relationships evolve over time.

Telemedicine Adoption and Utilization

The Physicians database product now also includes proprietary insights around telemedicine adoption by more than two million healthcare professionals, enabling clients to identify patterns about utilization by clinical practice area, region, and specialty, as well as how that utilization has changed. The COVID pandemic has accelerated telemedicine adoption, and the new telemedicine analytics will help Definitive Healthcare clients understand how to take advantage of the opportunities created by the increased use of virtual care delivery.

Definitive Healthcare has more than 2,500 clients – including 9 of the top 10 U.S. pharmaceutical and medical device companies. These world leading organizations rely on Definitive Healthcare data to provide unique, actionable insights to guide go-to-market planning; market and sales intelligence and optimization; and product and corporate development. Via its recent acquisition of Monocl, Definitive Healthcare also offers solutions for clients to identify and engage global scientific and medical experts with the greatest knowledge, influence and relevancy within the disease categories that they address.

About Definitive Healthcare

Definitive Healthcare is the most comprehensive and accurate source for data insights and analytics on the healthcare provider and influencer market. Its product suite provides the most comprehensive and highest quality data available anywhere on 9,100 hospitals and IDNs; 124,000 physician groups; 2 million physicians, nurses, and allied health professionals; 11,300 ambulatory surgery centers; 17,500 imaging centers; 96,000 long-term care facilities; 45,000 clinics; 2,300 ACOs and HIEs; 7.38 billion medical commercial claims covering 315 million patient lives, and insights on millions of global scientific and medical experts in life sciences and healthcare. The company’s data provides its more than 2,500 clients with the analytics and insight needed to effectively segment and research the healthcare provider market. Definitive Healthcare is backed by Advent International, Spectrum Equity, and 22C Capital. For more information, or to trial a solution, visit https://www.definitivehc.com/.